| Ticker Details |
|
Shattuck Labs, Inc.
|
| IPO Date: |
October 9, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$755.74M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.37 | 4.63%
|
| Avg Daily Range (30 D): |
$0.31 | 4.29%
|
| Avg Daily Range (90 D): |
$0.29 | 4.62%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.4M |
| Avg Daily Volume (30 D): |
.99M |
| Avg Daily Volume (90 D): |
.86M |
| Trade Size |
| Avg Trade Size (Sh.): |
130 |
| Avg Trade Size (Sh.) (30 D): |
74 |
| Avg Trade Size (Sh.) (90 D): |
81 |
| Institutional Trades |
| Total Institutional Trades: |
265 |
| Avg Institutional Trade: |
$2.23M |
| Avg Institutional Trade (30 D): |
$.89M |
| Avg Institutional Trade (90 D): |
$1.83M |
| Avg Institutional Trade Volume: |
.25M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.96M |
| Avg Closing Trade (30 D): |
$.65M |
| Avg Closing Trade (90 D): |
$2.32M |
| Avg Closing Volume: |
270.94K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$-.47
|
$-.12
|
$-.13
|
|
Diluted EPS
|
$-.47
|
$-.12
|
$-.13
|
|
Revenue
|
$1M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-52.57M
|
$-15.15M
|
$-14.77M
|
|
Operating Income / Loss
|
$-55.79M
|
$-16.16M
|
$-15.55M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$12.83M
|
$-27.12M
|
$36.23M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Dec 06, 2016
|
1:800
|
|
Mar 31, 2009
|
1:250
|
|
|
|